Laura Damme's most recent trade in Transmedics Group Inc was a trade of 8,705 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 20, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Transmedics Group Inc | Laura Damme | VP, Clinical Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2023 | 8,705 | 8,705 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | Laura Damme | VP, Clinical Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2023 | 5,685 | 5,685 (0%) | 0% | 0 | Common Stock | |
| Transmedics Group Inc | Laura Damme | VP, Clinical Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 38,000 | 38,000 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | Laura Damme | VP, Clinical Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2021 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) |